Table 1.
Correlation of miR-145 expression with clinicopathological factors of PTC patients
| Parameters | Patients | miR-145 relative expression | P |
|---|---|---|---|
| Total gender | 57 | 0.641 | |
| Male | 14 (24.6) | 3.71±1.54 | |
| Female | 43 (75.4) | 3.48±1.43 | |
| Age (Y) | 0.213 | ||
| ≥45 | 33 (57.9) | 3.37±1.57 | |
| < 45 | 24 (42.1) | 3.83±1.34 | |
| Tumor size, cm | 0.097 | ||
| ≥2 | 25 (43.9) | 3.29±1.75 | |
| < 2 | 32 (56.1) | 3.85±1.09 | |
| Extrathyroidal invasion | 0.116 | ||
| Yes | 13 (22.8) | 3.38±2.02 | |
| No | 44 (77.2) | 3.95±1.17 | |
| Multicentricity | 0.437 | ||
| Yes | 18 (31.6) | 3.40±1.24 | |
| No | 39 (68.4) | 3.89±1.57 | |
| Cervical metastasis status | 0.022 | ||
| N+ | 23 (45.6) | 2.87±1.60 | |
| N- | 34 (54.4) | 4.54±1.37 | |
| TNM stages | 0.041 | ||
| I/II | 31 (54.4) | 4.21±1.26 | |
| III/IV | 26 (45.6) | 2.71±1.71 |
Note: Values in parentheses represent percentages.